Drug Type Prophylactic vaccine |
Synonyms recombinant VSV (Mayo Clinic/NCI) |
Target |
Action modulators |
Mechanism IFNβ modulators(Interferon beta modulators), TYRP1 modulators(Tyrosinase-related protein 1 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Uveal Melanoma | Phase 1 | United States | 12 Jun 2019 | |
Uveal Melanoma | Phase 1 | United States | 12 Jun 2019 |
AACR2023 Manual | Phase 1 | 12 | (kurkaaxfhx) = vhuuwfaqdv eqhgedszmq (bvyfwqtoby ) View more | Positive | 14 Apr 2023 |